Frequency Therapeutics Inc (KRRO) stock has hit a 52-week low, trading at $29.8, marking a significant downturn for the company within the past year. According to InvestingPro data, the company ...

Cognito Therapeutics today announced the appointment of four new executives to accelerate its growth and commercialization ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.BoQAct6R.js ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...

IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced positive topline data from its Phase ...

This study found that oxytocin had particularly strong effects in women, promoting lower blood pressure and reducing norepinephrine, a hormone associated with the body’s stress response. Additionally, ...

PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...

The study shows that 94% of patients eliminated factor IX prophylaxis and maintained near-normal factor IX levels through ...

Broken String's new INDUCE-seq Early Access Program enables detection of on- and off-target edits at high resolution in days, in your lab Replaces months-long process of building technology ...

TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...

An expert answers questions about physical therapy for psoriatic arthritis, from what to look for in a provider to what to ...

Transient absorption spectroscopy of rose bengal reveals triplet state dynamics, crucial for optimizing photosensitizers in ...